Small molecule focus ProPharma Services specializes in early discovery, lead optimization, and IND enabling studies for small molecules, presenting an opportunity to position them as a partner for early-stage drug development and depletion of internal capability gaps.

PK/PD expertise With strong pharmacokinetics and toxicokinetics capabilities including ADME, CYP phenotyping, and PK/PD modeling, there is potential to upsell integrated PK support packages for clients needing robust preclinical to clinical transition analyses.

IND documentation Extensive experience in IND/IB/CTD writing and generation of IND enabling documents suggests a path to target biotech and small biotech sponsors seeking efficient regulatory documentation and GLP-ready processes.

Boutique flexibility As a small consultancy with a lean team, ProPharma offers customized, audit-ready procedures and rapid turnaround, appealing to early-phase companies that require hands-on, cost-effective pharmacology and regulatory support.

Strategic partnerships Potential to collaborate with mid-size CRO networks or larger sponsors lacking in specialized PK/PD services, enabling referral relationships or co-bid opportunities to expand service footprint without large-scale investments.